COMMUNIQUÉS West-GlobeNewswire

Hemispherx Announces Presentation on the Potential Role of Ampligen as an Immune System Amplifier Improving Seasonal Flu Vaccine Cross-Protection

26/01/2018 - 14:30

ORLANDO, Fla., Jan. 26, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), focused on pharmaceutical research, announces that William Mitchell, MD, PhD, Professor of Pathology, Microbiology & [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

26/01/2018 - 14:01

FIT Biotech Oy Company release January 26, 2018 at 03:00 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]

Premier Biomedical, Inc. CEO Letter -- January, 2018

26/01/2018 - 14:00

DALLAS, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Greetings From The CEO And Staff At Premier Biomedical! It has been a very busy and eventful quarter, and an exceptionally fruitful year, for Premier Biomedical (OTCQB:BIEI). [...]

Medical-Grade Wearable Provider Biotricity Aims to Increase Patient Adherence

26/01/2018 - 14:00

REDWOOD CITY, Calif., Jan. 26, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB : BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring [...]

Kalytera Announces Issuance of Shares under Services Agreement with The Salzman Group of Israel

26/01/2018 - 14:00

SAN FRANCISCO and TEL AVIV, Israel, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX-V: KALY ) (OTCQB:KALTF) (the " Company " or " Kalytera ") today announced that the Company has elected to issue 396, [...]

OPKO Health Announces Leadership Changes at BioReference Laboratories

26/01/2018 - 14:00

MIAMI, Jan. 26, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK ), announces that Gregory Henderson, M.D., Ph.D., has resigned from his position as President of BioReference Laboratories, an OPKO Health company [...]

BeyondSpring Presents Promising Data for Lead Asset Plinabulin at 2018 ASCO-SITC Clinical Immuno-Oncology Symposium

26/01/2018 - 14:00

Plinabulin and Neulasta have Very Similar Grade 4 Neutropenia Incidence and Duration of Severe Neutropenia (DSN) in the Phase 2 Portion of Phase 2/3 Trial Study 105 with Docetaxel-Induced Neutropenia Initial Phase 1 [...]

XBiotech Announces Presentation of Data from Phase 2 Study Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa

26/01/2018 - 14:00

AUSTIN, Texas, Jan. 26, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT ) announced today additional data analysis of its Phase 2 study evaluating XBiotech’s True Human™ antibody, MABp1, as a treatment for [...]

Emerald Health Therapeutics and DMG Blockchain Solutions Establish LOI to Create Cannabis Supply Chain Management System and E-Commerce Platform

26/01/2018 - 13:47

VICTORIA, British Columbia, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) and Emerald Health Sciences, Inc. (together, “Emerald”) and DMG Blockchain Solutions Inc. (“DMG”) [...]

REPEAT: Cannabis Wheaton Income Corp. Announces New Streaming Partner and Plans to Convert Former Nestle Facility for Cannabis Cultivation

26/01/2018 - 13:30

VANCOUVER, British Columbia, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V: CBW ) (" Wheaton Income " or "Wheaton" or the " Company ") is pleased to announce that it has [...]

IRADIMED CORPORATION to Hold 2017 Fourth Quarter Financial Results Conference Call on February 6th

26/01/2018 - 13:00

WINTER SPRINGS, Fla., Jan. 26, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD ) announced today that the Company will release its 2017 fourth quarter financial results before the market opens on Tuesday, [...]

Merus Announces First Patient Dosed in a Phase 2 Clinical Trial of MCLA-128 in Two Metastatic Breast Cancer Patient Populations

26/01/2018 - 13:00

UTRECHT, the Netherlands, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS ), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that [...]

Twinlab to Streamline Operations to Maximize Shareholder Value

26/01/2018 - 12:00

BOCA RATON, Fla., Jan. 26, 2018 (GLOBE NEWSWIRE) -- Twinlab Consolidated Holdings, Inc. (OTCPK:TLCC) announced yesterday, as part of improving operational efficiencies, it will transition the manufacturing of the [...]

Company announcement, Helsinki, 26 January 2018 at 11.00

26/01/2018 - 10:01

Company announcement, Helsinki, 26 January 2018 at 11.00 Subscription of new shares based on stock options plan 2013A Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a medical technology company [...]

Saniona AB: Saniona and Proximagen extend research collaboration

26/01/2018 - 08:01

PRESS RELEASE January 26, 2018 Saniona, a leading biotech company in the field of ion channels, today announced that Saniona and Proximagen have initiated lead optimization in their ongoing drug discovery and [...]

Santhera Receives Negative CHMP Opinion on Appeal for Authorization of Raxone® in Duchenne Muscular Dystrophy

26/01/2018 - 07:01

Liestal, Switzerland, January 26, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) maintained its negative [...]

Cannabis Wheaton Income Corp. Announces New Streaming Partner and Plans to Convert Former Nestle Facility for Cannabis Cultivation

26/01/2018 - 06:01

VANCOUVER, British Columbia, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Wheaton Income " or "Wheaton" or the " Company ") is pleased to announce that it has [...]

resTORbio Announces Pricing of Initial Public Offering

26/01/2018 - 01:55

BOSTON, Jan. 25, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases, [...]

Cannabis Wheaton Income Corp. Comments on Recent Market Activity

26/01/2018 - 01:00

VANCOUVER, British Columbia, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (OTCQB:CBWTF) (" Wheaton Income " or the " Company ") wishes to make the following [...]